90 related articles for article (PubMed ID: 10731947)
1. [The effectiveness of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of non-Hodgkin's lymphoma in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubała H; Drabko K; Eliasińska A; Kedziora M; Sońta-Jakimczyk D; Sopyło B; Kołecki P; Kowalczyk J; Matysiak M; Rokicka-Milewska R; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M; Płoszyńska A
Wiad Lek; 1998; 51 Suppl 4():72-8. PubMed ID: 10731947
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of solid tumors in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubała H; Drabko K; Eliasińska A; Kedziora M; Kołecki P; Kowalczyk J; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M
Wiad Lek; 1998; 51 Suppl 4():65-71. PubMed ID: 10731946
[TBL] [Abstract][Full Text] [Related]
3. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of acute leukemia in children].
Rokicka-Milewska R; Pawelec K; Bogusławska-Jaworska J; Chybicka A; Rosińska B; Stańczak E; Matysiak M; Sońta-Jakimczyk D; Bubała H; Kołecki P; Boruczkowski D; Wysocki M; Kurylak A
Wiad Lek; 1998; 51 Suppl 4():59-64. PubMed ID: 10731945
[TBL] [Abstract][Full Text] [Related]
4. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
5. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas].
Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J
Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
7. [G-CSF and GM-CSF in treatment of neutropaenia after chemotherapy in children with neoplasms].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubala H; Drabko K; Eliasinska A; Kedziora M; Sońta-Jakimczyk D; Sopylo B; Kołecki P; Kowalczyk J; Matysiak M; Rokicka-Milewska R; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M; Płoszyńska A
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):121-9. PubMed ID: 12021471
[TBL] [Abstract][Full Text] [Related]
8. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
9. [Use of rHu GM-CSF (Leucomax) in treatment of neutropenia during intensive chemotherapy for acute lymphoblastic leukemia].
Rokicka-Milewska R; Derulska D; Pawelec K
Acta Haematol Pol; 1994; 25(2):111-8. PubMed ID: 8067182
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer.
Riikonen P; Rahiala J; Salonvaara M; Perkkiö M
Stem Cells; 1995 May; 13(3):289-94. PubMed ID: 7542114
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
12. [G-CSF in practice: malignant non-Hodgkin's lymphomas].
Rossi JF
Pathol Biol (Paris); 1993 Jan; 41(1):44-5. PubMed ID: 7686283
[No Abstract] [Full Text] [Related]
13. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
14. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
Lehrnbecher T; Creutzig U
Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
Zumberg MS; Leather HL; Nejame C; Meyer C; Wingard JR
Cytotherapy; 2002; 4(6):531-8. PubMed ID: 12568989
[TBL] [Abstract][Full Text] [Related]
16. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
17. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
Hashino S; Morioka M; Irie T; Shiroshita N; Kawamura T; Suzuki S; Iwasaki H; Umehara S; Kakinoki Y; Kurosawa M; Kahata K; Izumiyama K; Kobayashi H; Onozawa M; Takahata M; Fujisawa F; Kondo T; Asaka M
Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
[TBL] [Abstract][Full Text] [Related]
18. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma.
Doorduijn JK; Buijt I; van der Holt B; van Agthoven M; Sonneveld P; Uyl-de Groot CA
Haematologica; 2004 Sep; 89(9):1109-17. PubMed ID: 15377472
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
